Compare DXPE & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DXPE | BHC |
|---|---|---|
| Founded | 1908 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 1998 | 1996 |
| Metric | DXPE | BHC |
|---|---|---|
| Price | $152.82 | $5.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $154.00 | $8.33 |
| AVG Volume (30 Days) | 137.0K | ★ 1.4M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.25 | ★ 423.08 |
| EPS | ★ 5.37 | 0.42 |
| Revenue | $1,247,043,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $9.31 | $4.61 |
| Revenue Next Year | $7.85 | N/A |
| P/E Ratio | $28.27 | ★ $12.82 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $75.58 | $4.28 |
| 52 Week High | $171.70 | $8.69 |
| Indicator | DXPE | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 67.36 | 55.89 |
| Support Level | $112.79 | $5.52 |
| Resistance Level | $154.19 | $5.62 |
| Average True Range (ATR) | 6.69 | 0.19 |
| MACD | 1.78 | 0.07 |
| Stochastic Oscillator | 90.30 | 91.43 |
DXP Enterprises Inc is engaged in the business of distributing maintenance, repair and operating (MRO) products, equipment and service to customers in various end markets, including general industrial, energy, food & beverage, chemical, transportation, water and wastewater. The company operates through three business segments: Service Centers, Innovative Pumping Solutions and Supply Chain Services. The majority of revenue is derived from the Service Centers segment, which provides a wide range of MRO products in the rotating equipment, bearing, power transmission, hose, fluid power, metal working, fastener, industrial supply, safety products and safety services categories. Geographically, it generates the maximum revenue from the United States.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.